Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis.
Brigida BarberioJonathan P SegalM Nabil QuraishiChristopher J BlackEdoardo Vincenzo SavarinoAlexander C FordPublished in: Journal of Crohn's & colitis (2021)
Our results support previous evidence; however, higher doses of oral mesalazine had more evidence for induction of remission than combined therapy and were significantly more efficacious than lower doses. Future RCTs should better establish the role of combined therapy for induction of remission, as well as optimal doses of oral 5-ASAs to prevent relapse.